Cart
sales@molnova.com
Cabotegravir
CAS No. 1051375-10-0
Cabotegravir ( S/GSK1265744;GSK 744; Cabotegravir )
Catalog No. M17126 CAS No. 1051375-10-0
Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC50: 3.0 nM).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | In Stock |
|
| 25MG | 80 | In Stock |
|
| 50MG | 142 | In Stock |
|
| 100MG | 178 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCabotegravir
-
NoteResearch use only, not for human use.
-
Brief DescriptionCabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC50: 3.0 nM).
-
DescriptionCabotegravir, also known as S/GSK1265744 or GSK744, is potent HIV integrase inhibitor under development for the treatment of HIV infection. Cabotegravir has a carbamoyl pyridone structure similar to dolutegravir.
-
SynonymsS/GSK1265744;GSK 744; Cabotegravir
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIV integrase
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1051375-10-0
-
Formula Weight405.35
-
Molecular FormulaC19H17F2N3O5
-
Purity98%
-
SolubilityDMSO : 12.67 mg/mL 31.26 mM;
-
SMILESC[C@H]1CO[C@H]2N1C(=O)c1c(c(=O)c(cn1C2)C(=O)NCc1c(cc(cc1)F)F)O
-
Chemical Name(3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yoshinaga T, et al. Antimicrob Agents ChemOthers. 2015, 59(1), 397-406.
molnova catalog
related products
-
Platycodin J
The roots of Platycodon grandiflorum.
-
MM 07
Apelin biased agonist; exhibits bias for the G protein pathway. Stimulates endothelial NOS phosphorylation and expression, promotes proliferation, and attenuates apoptosis of human pulmonary arterial endothelial cells in vitro. Shows positive inotropic and vasodilatory effects in vivo and improves cardiac structure and function in a model of pulmonary arterial hypertension.
-
CLIP (human) (TFA)
Adrenocorticotropic Hormone (ACTH) (18-39), human TFA is a corticotropinlike intermediate lobe peptide, which is is produced in the melanotrophs of the intermediate lobe of the pituitary.
